Transforming Global Healthcare by Advancing Digital Therapeutics

Digital therapeutics (DTx) are changing the healthcare delivery system with evidence-based technologies that improve patient outcomes.

Learn About DTx

"After using Freespira I have been able to manage my stress and anxiety, and panic attacks feel like a distant memory. I'm excited to help others live a panic-free life as well."

Talia, United States

“JOGO has reduced my tremors considerably. I am able to sleep better after using JOGO before going to bed.”

Hugh, United States

“Dario has helped me manage my diabetes, because I now know how my body reacts to different foods and meals. Before Dario, my A1c was 9.7. Now its 5.7.”

Richard J., United States

Understanding DTx

DTx products deliver software-based interventions to patients to treat, manage, or prevent a disease or disorder.

Learn More

Value of DTx

Digital therapeutics increase access to clinically validated therapies that directly improve patient outcomes.

Learn More

Advancing DTx

The Digital Therapeutics Alliance (DTA) is the leading international organization on digital therapeutic thought leadership and education.

Learn More

Embarking on a new era for digital therapeutics

DTA developed the Policymaker & Payor DTx Evaluation Toolkit to provide a common language and process for HCDMs and DTx manufacturers to jointly use throughout DTx product evaluation and implementation processes. It addresses a wide spectrum of HCDM considerations across various settings—ranging from health systems, employers, and private payors, to single-payor government systems—and will continue to be updated to ensure ongoing relevance in this quickly evolving ecosystem.

Learn More about the DTx Evaluation Toolkit

Taking the Lead in Global DTx Advancement

The Digital Therapeutics Alliance is a global non-profit trade association of industry leaders and stakeholders engaged in the advancement of evidence-driven digital therapeutics.

DTA works to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics into healthcare through education, advocacy, and cross-industry collaboration. DTA maintains an international industry presence and is proud to work with members from 17 countries spread across five continents.

Join DTA's Global Efforts

Global Industry Presence

Members are working around the world to improve clinical and health economic outcomes.

DTA Members Are Transforming Healthcare

Member organizations play a critical role in transforming healthcare by delivering an impressive array of therapeutic interventions that improve clinical and health economic outcomes. Learn more about DTA and member company contributions.

DTA Releases & Statements

Board Nominations Now Open: Digital Therapeutics Alliance Seeks Visionary Leaders to Represent the Diverse Membership and Global Ecosystem”

September 18, 2023

DTA Releases & Statements

Digital Therapeutics Alliance Launches Policymaker & Payor DTx Evaluation Toolkit to Accelerate Global Digital Therapeutic Understanding and Adoption

June 14, 2023

All News